NCT07308886 2026-03-19
Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting
Clinical Trials
9 trialsNCT03258567 2026-03-06
Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting
NCT07445984 2026-03-03
Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021)
Azienda Ospedaliero-Universitaria di Parma
Phase NA Recruiting
NCT01555892 2026-03-02
GRALE
Baylor College of Medicine
Phase 1 Recruiting
NCT02402244 2026-02-27
Project: Every Child for Younger Patients With Cancer
Children's Oncology Group
Recruiting
NCT05898789 2026-02-25
Virtual Rehabilitation for Cancer Survivors
University Health Network, Toronto
Phase NA Recruiting
NCT03394365 2026-02-20
ALLELE
Pierre Fabre Medicament
Phase 3 Recruiting
NCT04554914 2026-02-20
A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases
Pierre Fabre Medicament
Phase 2 Recruiting
NCT00032513 2026-02-17
Genetic Studies of Chronic Active Epstein-Barr Disease
National Institutes of Health Clinical Center (CC)
Recruiting